The ROE (Return on Equity) of Neogenomics Inc (NEO) is -8.72%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -8.72% |
| 2023-12-31 | -9.34% |
| 2022-12-31 | -14.46% |
| 2021-12-31 | -0.75% |
| 2020-12-31 | 0.60% |
| 2019-12-31 | 1.58% |
| 2018-12-31 | 0.81% |
| 2017-12-31 | -0.20% |
| 2016-12-31 | -3.27% |
| 2015-12-31 | -1.05% |